I think iMed sales are slow, if they had something positive to say would have thought they would be telling us the demand has been strong etc but they seem reserved.
Company does not seem that bullish on US deals either, far cry from the 08/10/2020 release! They have been advancing pilots for 18 months, if this is the length of effort and time to get one hospital on board god help us.
Overall a dour report, hard to see when we will get any real revenue of note, the 08/10/2020 immediate $132.1 million opportunity has become a near term pipeline with no mention of any further details. Nothing on Medicare/US equivalent update.
Ann: 4DMedical Reports 1H FY22 Results, page-2
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 4DX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
52.0¢ |
Change
-0.050(8.77%) |
Mkt cap ! $203.5M | |||
| Open | High | Low | Value | Volume |
| 57.0¢ | 57.0¢ | 51.5¢ | $1.080M | 2.010M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 21197 | 52.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 52.5¢ | 4369 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| 4DX (ASX) Chart |